🇺🇸 FDA
Patent

US 11180466

2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors

granted A61KA61K31/167A61K31/40

Quick answer

US patent 11180466 (2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors) held by University College Cardiff Consultants Limited expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University College Cardiff Consultants Limited
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/167, A61K31/40, A61K31/4402, A61K31/4453